Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Taiwan J Obstet Gynecol ; 50(3): 292-6, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22030041

RESUMEN

OBJECTIVES: The abdominopelvic cavity is one of the common sites for extrapulmonary tubercular infections. The rate of preoperative misdiagnoses between peritoneal tuberculosis (TB) and ovarian cancer is high because of overlapping nonspecific signs and symptoms. We attempted to analyze the experience within our hospital so as to establish the best means of discriminating between peritoneal TB and advanced ovarian cancer. METHODS: Seventeen patients diagnosed as having peritoneal TB between July 1986 and December 2008 at the Obstetrics and Gynecology Department of our hospital with the initial presentation simulating advanced ovarian cancer were retrospectively reviewed and evaluated. RESULTS: Patients' ages ranged from 24 years to 87 years (median, 38 years). Ten of 17 patients (60%) were younger than 40 years. All patients except one had elevated serum cancer antigen-125 levels with a mean of 358.8 U/mL (range, 12-733 U/mL). Computed tomographic (CT) scans showed ascites with mesenteric or omental stranding in all (100%), enlarged retroperitoneal lymph nodes in six (35.3%), and an adnexal mass in three (17.6%). Abdominal paracentesis was performed in seven cases, in which the findings revealed lymphocyte-dominant ascites without malignant cells. Surgical intervention by laparotomy was performed in 13 cases (76%) and by laparoscopy in three cases (18%), and a CT-guided peritoneal biopsy was performed in one case (6%). A frozen section was taken from 16 patients but not the patient who received a CT-guided peritoneal biopsy, and all revealed granulomatous inflammation. A final pathological examination confirmed a diagnosis of peritoneal TB. All patients responded to anti-TB treatment. CONCLUSIONS: In view of these data, a clinical diagnosis of peritoneal TB should be considered in a relatively young female with nonspecific symptoms of abdominal distension and wasting, as well as lymphocytic ascites without malignant cells. Laparoscopy or a minilaparotomy to obtain tissue samples for frozen-section analysis may be the most direct and least-invasive approach for a diagnosis, thus avoiding unnecessary extended surgery in these patients.


Asunto(s)
Neoplasias Ováricas/diagnóstico por imagen , Peritonitis Tuberculosa/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Anciano , Anciano de 80 o más Años , Ascitis/diagnóstico por imagen , Ascitis/microbiología , Ascitis/patología , Líquido Ascítico/diagnóstico por imagen , Líquido Ascítico/microbiología , Líquido Ascítico/patología , Antígeno Ca-125/sangre , Diagnóstico Diferencial , Femenino , Humanos , Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/microbiología , Enfermedades Linfáticas/patología , Persona de Mediana Edad , Neoplasias Ováricas/patología , Peritoneo/diagnóstico por imagen , Peritoneo/microbiología , Peritoneo/patología , Peritonitis Tuberculosa/patología , Estudios Retrospectivos , Adulto Joven
2.
Jpn J Clin Oncol ; 35(11): 651-4, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16275678

RESUMEN

OBJECTIVE: We attempted to evaluate the therapeutic effect of trichloroacetic acid (TCA) for vaginal intraepithelial neoplasia (VaIN) after hysterectomy and to identify factors affecting persistence/recurrence. METHODS: Twenty-eight post-hysterectomy patients with various grades of VaIN were enrolled in this study between January 2001 and December 2003. They were managed with intravaginal 50% TCA once weekly for 1-4 weeks, and all patients were followed up every 3 months for at least 1 year. Assessments by Papanicolaou smear and colposcopy were performed, as was biopsy when indicated during the follow-up period. Cox regression analysis was used to identify independent factors predicting persistence/recurrence. RESULTS: In 20 of 28 patients (71.4%) VaIN went into remission. Treatment success was observed in all 11 patients with VaIN I, whereas only 9 out of 17 patients (53%) with VaIN II/III went into remission (P = 0.009). Severity of VaIN was the only significant independent predictor of persistence/recurrence (odds ratio = 3.5; 95% confidence interval = 1.1, 11.6; P = 0.038). The treatment was well tolerated with no major side effects. CONCLUSIONS: Based on our findings, 50% TCA was a potential agent with minimal side effects for low-grade VaIN. Further prospective controlled study is warranted to verify our statements. However, as for high-grade lesions, further investigation with different TCA concentration is compelling.


Asunto(s)
Carcinoma in Situ/tratamiento farmacológico , Histerectomía , Ácido Tricloroacético/uso terapéutico , Neoplasias Vaginales/tratamiento farmacológico , Administración Tópica , Adulto , Anciano , Carcinoma in Situ/cirugía , Esquema de Medicación , Femenino , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia/tratamiento farmacológico , Cuidados Posoperatorios , Ácido Tricloroacético/administración & dosificación , Neoplasias Vaginales/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA